×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ELDN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
08:32 am
eldn
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Medium
Report
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/14
06:27 am
eldn
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions [Yahoo! Finance]
11/12
04:12 pm
eldn
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
11/12
04:01 pm
eldn
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
High
Report
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
11/6
04:05 pm
eldn
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
Low
Report
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
10/29
07:46 am
eldn
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
10/29
07:45 am
eldn
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Medium
Report
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:01 pm
ELDN
eledon pharmaceuticals, inc.
MISS
Report
-10.5%
eledon pharmaceuticals, inc.
8/19/2024
04:36 pm
ELDN
eledon pharmaceuticals, inc.
MISS
Report
2.5%
eledon pharmaceuticals, inc.
5/9/2024
07:30 am
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
-1.6%
eledon pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/20
08:00 am
eldn
Form 8-K Eledon Pharmaceuticals, For: Dec 16
Medium
Report
Form 8-K Eledon Pharmaceuticals, For: Dec 16
11/22
05:01 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Perrin Steven
Neutral
Report
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Perrin Steven
11/22
05:01 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Little Paul Sean
Neutral
Report
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Little Paul Sean
11/22
05:00 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Smith Bryan E.
Neutral
Report
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Smith Bryan E.
11/22
05:00 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Gros David-Alexandre C
Neutral
Report
Form 4 Eledon Pharmaceuticals, For: Nov 21 Filed by: Gros David-Alexandre C
11/14
04:52 pm
eldn
Form SC 13G/A Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Medium
Report
Form SC 13G/A Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
11/12
05:01 pm
eldn
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
High
Report
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
11/12
04:05 pm
eldn
Form 8-K Eledon Pharmaceuticals, For: Nov 12
High
Report
Form 8-K Eledon Pharmaceuticals, For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: